|
Secondary prevention
Citations 411-420 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Cardiology: New Frontiers
Principles From Clinical Trials Relevant to Clinical Practice: Part I
- Robert M. Califf and David L. DeMets
Circulation 2002;106:1015-1021, doi:10.1161/01.CIR.0000023260.78078.BB
[Full text]
- Correspondence
Primary Prevention Lipid-Lowering Drug Therapy • Response
- Donald O. Fedder, Carol E. Koro, Gilbert J. L’Italien, Antonio M. Gotto, Jr, and Lewis H. Kuller
Circulation 2002;106:e35-36e, doi:10.1161/01.CIR.0000025828.88749.55
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
- David L. DeMets and Robert M. Califf
Circulation 2002;106:880-886, doi:10.1161/01.CIR.0000023220.26465.89
[Full text]
- Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
- Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation 2002;106:666-671; published online before print as doi:10.1161/01.CIR.0000024413.15949.ED
[Abstract]
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part I
- David L. DeMets and Robert M. Califf
Circulation 2002;106:746-751, doi:10.1161/01.CIR.0000023219.51483.66
[Full text]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:626-630, doi:10.1161/01.CIR.0000021408.40925.63
[Full text]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:516-520, doi:10.1161/01.CIR.0000021407.93752.7B
[Full text]
- Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
- Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation published July 22, 2002, doi:10.1161/01.CIR.0000024413.15949.ED
[Abstract]
- Correspondence
Low High-Density Lipoprotein Cholesterol and Response to Simvastatin Therapy in Scandinavian Simvastatin Survival Study (4S) • Response
- Sander Robins, Christie M. Ballantyne, Anders G. Olsson, Thomas J. Cook, Michele F. Mercuri, Terje R. Pedersen, and John Kjekshus
Circulation 2002;106:e8, doi:10.1161/01.CIR.0000019970.99823.B2
[Full text]
- Clinical Investigations and Reports
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment: The Losartan Intervention for Endpoint (LIFE) Study
- Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation 2002;106:227-232; published online before print as doi:10.1161/01.CIR.0000021601.49664.2A
[Abstract]
[Full text]
|
|
